-
(S)-3-(4-(1-((4'-(tert-Butyl)-2,6-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-4,4,4-trifluorobutyl)benzamido)propanoic acid
-
BD6292661488363-78-598%
-
¥1224.05mg
-
Human glucagon
-
BD13209316941-32-599%
-
¥1068.050mg
-
(4S,7S,10S,13S,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-(((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-12-(4-aminobutyl)-27-((S)-sec-butyl)-6-carbamoyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-yl)carbamoyl)-58-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-16-(3-amino-3-oxopropyl)-7-(4-aminobutyl)-49-benzyl-22-(2-carboxyethyl)-40-(carboxymethyl)-28-(4-hydroxybenzyl)-46,52-bis((R)-1-hydroxyethyl)-31,34,43-tris(hydroxymethyl)-25-isobutyl-37-isopropyl-10,13-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaazahenhexacontanedioic acid
-
BD132094107444-51-998%
-
¥2992.01mg
-
(E)-N-(2-Aminophenyl)-3-(1-((4-(1-methyl-1H-pyrazol-4-yl)phenyl)sulfonyl)-1H-pyrrol-3-yl)acrylamide 4-methylbenzenesulfonate
-
BD6299631186222-89-898+%
-
¥
-
glucagon receptor antagonists-1
-
BD234875503559-84-098+%
-
¥3852.010mg
-
Liraglutide
-
BD136402204656-20-298%
-
¥650.010mg
-
Loureirin C
-
BD689578956103-79-097%
-
¥5439.01g
-
Exendin (9-39)
-
BD114767133514-43-999%
-
¥4123.05mg
-
Exendin-4
-
BD689155141758-74-997%
-
¥294.010mg
-
Methyl (1S,4aS,5R,7S,7aS)-5,7-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
-
BD15108364421-28-997%
-
¥800.025mg
-
3-(4-((1-(trans-4-(tert-Butyl)cyclohexyl)-3-(4-(trifluoromethoxy)phenyl)ureido)methyl)benzamido)propanoic acid
-
BD764622307983-31-998%
-
¥421.02mg
-
4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
-
BD7655851371569-69-597%
-
¥1701.0100mg
-
Semaglutide
-
BD00800278910463-68-299%
-
¥4740.010mg
-
Lixisenatide
-
BD01077738320367-13-399+%
-
¥478.05mg
-
(S)-2-((4-(6-((4-Cyano-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-carboxylic acid
-
BD010937772230198-02-298%
-
¥2245.050mg
-
GLP-1(7-36) xAcetate
-
BD011403251119517-19-999%
-
¥
-
Teduglutide
-
BD01173691197922-42-298%
-
¥1470.01mg
-
3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl
-
BD011246282212020-52-398%
-
¥2444.050mg
-
4-((1-(4-Cyclohexylphenyl)-3-(3-(methylsulfonyl)phenyl)ureido)methyl)-N-(1H-tetrazol-5-yl)benzamide
-
BD01104870307986-98-798%
-
¥4120.050mg
-
GLP-1R modulator C5
-
BD01473151421578-93-098%
-
¥